No Racial Disparities in Survival Seen in Prostate Cancer Trial
Outcomes were similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors in a phase 3 trial.
Outcomes were similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors in a phase 3 trial.
As many as 55% of patients with cancer may be affected by food insecurity.
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Historically redlined census tracts were significantly less likely to meet targets for breast, colon, and cervical cancer screening.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Patterns of melanoma presentation, disease severity, and mortality vary by race among men, a study suggests.
Differences in socioeconomic and insurance status partly explain the differences in cardiovascular disease-related death between Black and White cancer survivors, researchers say.
Black patients who were seriously ill reported a high frequency of discrimination and microaggressions in health care.
Indigenous men are less likely to receive PSA testing and more likely to be diagnosed with higher-risk prostate cancer, a study suggests.
The American Heart Association has released a statement on inequities in cardio-oncology care and research.